Location History:
- N. Stonington, CT (US) (2003 - 2004)
- North Stonington, CT (US) (2002 - 2006)
Company Filing History:
5 out of 4,455 
1 out of 832,843 Years Active: 2002-2006
Title: Christopher Stanley Poss: Innovator in Pharmaceutical Chemistry
Introduction
Christopher Stanley Poss is a notable inventor in the field of pharmaceutical chemistry. He is based in the United States and has made significant contributions to the development of compounds with therapeutic potential. His work primarily focuses on the design and synthesis of innovative pharmaceutical agents.
Latest Patents
Christopher Stanley Poss holds a patent titled "Piperazine Derivatives With CCR1 Receptor Antagonist Activity." This invention relates to compounds of a specific formula and their pharmaceutically acceptable forms. The patent outlines methods for using these compounds to treat or prevent disorders that can be addressed by antagonizing the CCR1 receptor in mammals. Although he has 6 patents, his research is pivotal in advancing pharmaceutical applications.
Career Highlights
Poss is currently associated with Pfizer Products Inc., a leading global biopharmaceutical company. His role involves extensive research and development aimed at creating effective therapeutic solutions. His expertise in pharmaceutical chemistry has positioned him as a valuable asset in the industry.
Collaborations
Throughout his career, Christopher has collaborated with several professionals, including Laura Cook Blumberg and Matthew Frank Brown. These collaborations have fostered a productive environment for innovation and research in pharmaceutical sciences.
Conclusion
Christopher Stanley Poss is a dedicated inventor whose work in pharmaceutical chemistry continues to influence the development of new therapeutic agents. His contributions, particularly in the area of CCR1 receptor antagonism, highlight the importance of innovation in addressing medical challenges.